Stevanato Group S.p.A. (NYSE:STVN) Short Interest Update

Stevanato Group S.p.A. (NYSE:STVNGet Rating) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 2,780,000 shares, an increase of 54.4% from the March 31st total of 1,800,000 shares. Currently, 8.2% of the shares of the stock are sold short. Based on an average daily volume of 309,100 shares, the days-to-cover ratio is presently 9.0 days.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Lazard Asset Management LLC lifted its stake in shares of Stevanato Group by 3.7% in the 4th quarter. Lazard Asset Management LLC now owns 6,156,672 shares of the company’s stock valued at $138,216,000 after purchasing an additional 222,395 shares in the last quarter. Norges Bank acquired a new position in shares of Stevanato Group in the 4th quarter valued at about $42,342,000. Morgan Stanley acquired a new position in shares of Stevanato Group in the 3rd quarter valued at about $32,099,000. Miura Global Management LLC lifted its stake in shares of Stevanato Group by 32.3% in the 4th quarter. Miura Global Management LLC now owns 1,191,000 shares of the company’s stock valued at $26,738,000 after purchasing an additional 291,000 shares in the last quarter. Finally, Goldman Sachs Group Inc. lifted its stake in shares of Stevanato Group by 17.2% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,091,835 shares of the company’s stock valued at $24,512,000 after purchasing an additional 160,100 shares in the last quarter. 12.40% of the stock is currently owned by institutional investors and hedge funds.

NYSE:STVN traded up €0.35 ($0.38) during mid-day trading on Friday, reaching €16.00 ($17.20). The company’s stock had a trading volume of 284,100 shares, compared to its average volume of 443,661. The company’s fifty day simple moving average is €17.61 and its two-hundred day simple moving average is €20.06. The company has a quick ratio of 2.12, a current ratio of 2.56 and a debt-to-equity ratio of 0.24. Stevanato Group has a twelve month low of €14.38 ($15.46) and a twelve month high of €29.18 ($31.38).

Stevanato Group (NYSE:STVNGet Rating) last released its quarterly earnings data on Tuesday, March 8th. The company reported €0.15 ($0.16) earnings per share for the quarter, beating the consensus estimate of €0.12 ($0.13) by €0.03 ($0.03). The business had revenue of €232.60 million for the quarter, compared to analyst estimates of €220.57 million. Stevanato Group had a return on equity of 21.52% and a net margin of 15.93%. Stevanato Group’s quarterly revenue was up 12.5% compared to the same quarter last year. On average, research analysts forecast that Stevanato Group will post 0.53 EPS for the current year.

STVN has been the subject of a number of recent research reports. Morgan Stanley dropped their price objective on Stevanato Group from $30.00 to $22.00 and set an “overweight” rating for the company in a research report on Wednesday, March 9th. Bank of America dropped their price objective on Stevanato Group from $30.00 to $24.00 and set a “buy” rating for the company in a research report on Wednesday, March 9th. Zacks Investment Research cut Stevanato Group from a “buy” rating to a “hold” rating in a research report on Thursday, March 10th. Wells Fargo & Company dropped their price objective on Stevanato Group from $21.00 to $19.00 and set an “overweight” rating for the company in a research report on Monday, April 25th. Finally, Citigroup decreased their price target on Stevanato Group from $27.00 to $23.00 and set a “buy” rating on the stock in a research note on Wednesday, March 9th. Two investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Buy” and a consensus target price of €24.44 ($26.28).

About Stevanato Group (Get Rating)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.

See Also

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.